Uroplasty, Inc. (AMEX: UPI), a global medical device company, is focused on developing, manufacturing, and marketing products for the minimally invasive treatment of voiding dysfunctions and pelvic disorders. The company offers a wide range of products that meet the demands of healthcare professionals and patients. Their devices help healthcare professionals increase the efficiency of their treatment options while reducing patient risk. For further information, visit the Company’s web site at www.uroplasty.com.
- 17 years ago
QualityStocks
Uroplasty, Inc. (AMEX: UPI)
Tags Rodman & Renshaw
Related Post
-
Xeriant Inc. (XERI) Builds Innovation Ecosystem Focused on Advanced Technologies, Commercialization
Xeriant is focused on acquiring, developing and commercializing transformative technologies with applications across multiple industrial…
-
TechForce Robotics Inc. (NGTF): Proving Practical Solutions for the Industry’s Fatigued Areas
Hospitality operators are adopting robotics to target the most physically demanding jobs in hotels, venues,…
-
Drilling Assay Results Boost Deposit Potential, Demonstrates High-Grade Gold Intervals and Continuity for LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF), Setting Stage for Forthcoming PEA
Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) and may…